---
schema_version: "secwatch.filing_event.v1"
accession: "0001001250-25-000097"
form_type: "8-K"
ticker: "EL"
cik: "0001001250"
company_name: "ESTEE LAUDER COMPANIES INC"
filed_at: "2025-08-20T23:59:59+00:00"
generated_at: "2026-05-17T11:02:44.465690+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Estée Lauder reports FY2025 net sales down 8% to $14.3B; GAAP EPS $(3.15); impairments and litigation charges weigh

## Summary
- Net sales $14.326B (down 8% YoY); GAAP diluted EPS $(3.15) vs $1.08; adjusted diluted EPS $1.51 vs $2.59.
- Adjusted operating margin 8.0% vs 10.2%; gross margin expanded 230 bps to 74.0% on PRGP benefits.
- Q4 net sales $3.411B (down 12%); Q4 op. loss $(390)M on ~$450M impairment charges (Dr.Jart+, TOM FORD, Too Faced) and $159M talcum litigation settlements.
- Affirms FY2026 outlook: expects organic sales growth (first growth after three declines) and improved operating profitability.
- Skin Care -12% driven by Estée Lauder/La Mer declines in Asia travel retail; Fragrance flat; Le Labo posted strong double-digit growth each quarter.

## SEC filing metadata
- accession: 0001001250-25-000097
- form_type: 8-K
- ticker: EL
- cik: 0001001250
- company_name: ESTEE LAUDER COMPANIES INC
- filed_at: 2025-08-20T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001250/000100125025000097/0001001250-25-000097-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001250/000100125025000097/el-20250820.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001001250-25-000097
- JSON: https://secwatch.observer/filing/0001001250-25-000097.json
- Plain text: https://secwatch.observer/filing/0001001250-25-000097.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.